Login
$ACUT
$0.16 +$0.00 (0.0%) Close

Ownership

13F as of Q2 2026 · 16.1M shares outstanding

Who owns ACUT?

By type of holder
Institutions 0.0% Insiders 88.1% Everyone else 11.9%
Concentration Top 1 holders own 88.1%
Cerrone Gabriel M 88.1%
Institutional ownership
0.0%
0.0 pts vs last qtr
Institutional holders
0
0 vs last qtr
Net shares bought
0
by institutions in Q2 2026
New / sold out
0 / 0
positions opened vs closed

How is ownership changing?

Institutions, last 8 quarters

Biggest buyers in Q2 2026

None.

Biggest sellers in Q2 2026

None.

Who is planning to sell?

No insider has filed a notice of proposed sale (Form 144) for Accustem Sciences Inc in the last 12 months.

Is your stake being diluted?

Diluted share count, FY2022–FY2025
+38.3%
+11.41% a year
Each share's claim on the business
−27.7%
shrank without buying or selling a share
Spent on buybacks vs paid in stock
— vs $371K
over 4 fiscal years
Diluted shares, split-adjusted
10.7M13.0M15.4M2022: 11.0M shares'222023: 11.3M shares'232024: 11.4M shares'242025: 15.2M shares'25
Buybacks Stock-based comp
$0$66.9K$133.9K2022 buybacks: $02022 stock comp: $133.9K'222023 buybacks: $02023 stock comp: $78.6K'232024 buybacks: $02024 stock comp: $69.7K'242025 buybacks: $02025 stock comp: $88.7K'25

How patient are the owners?

No 13F manager reports holding ACUT.

Super Investors

Investment managers reporting ACUT on Form 13F
No 13F manager reports holding ACUT yet.

Institutional Funds

Mutual funds and ETFs reporting ACUT on Form N-PORT; together they hold 0.0% of the company
SP
Position value
$3.86
% of company
0.00%
% of the fund
0.00%
As of
June 30, 2024

Insiders and 5%+ holders

From Forms 3/4/5 and Schedules 13D/G
CG
Cerrone Gabriel M
Insider
Shares
14.2M
% of company
88.09%
Change vs last qtr
—
Held since
—

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support